Earlier this year, Annette Bakker, PhD, President, Children’s Tumor Foundation, attended the BIO CEO & Investor Conference, a conference focused on bringing together investors with select biotech companies. While there, she gave interviews to two outlets, Check Rare and Financial Buzz.
Check Rare, a learning platform for healthcare professionals and the rare disease community, asked Annette about the CTF research strategy and R&D platform, which is leading to promising treatments in both NF1 and NF2.
Annette was also interviewed by Financial Buzz Media for ‘Behind the Buzz,’ a digital news outlet focused on financial news about the complexities of developing drug treatments and how Children’s Tumor Foundation investments are addressing this.
